Copyright
©The Author(s) 2023.
World J Gastrointest Endosc. May 16, 2023; 15(5): 407-419
Published online May 16, 2023. doi: 10.4253/wjge.v15.i5.407
Published online May 16, 2023. doi: 10.4253/wjge.v15.i5.407
Table 2 Has the patient taken any of the following medications in the past year
Drug | Yes | No | Maybe |
Claritin (loratadine) | |||
Zyrtec (cetirizine) | |||
Allegra (fexofenadine) | |||
Sudafed (pseudoephedrine) | |||
Singulair (montelukast) | |||
Rynatan (chlorpheniramine) | |||
Pro-Air, Ventolin (albuterol) | |||
Flovent (fluticasone) | |||
Pulmicort (budesonide) | |||
Advair (fluticasone/salmeterol) | |||
Orapred (prednisone) | |||
Xolair (omalizumab) | |||
Flonase (fluticasone) | |||
Nasonex (mometasone) | |||
Nasacort (triamcinolone) | |||
Rhinocort (budesonide) | |||
Veramyst (fluticasone) | |||
Omnaris (ciclesonide) | |||
Astelin (azelastine) | |||
Astepro (azelastine) | |||
Patanase (olopatadine) | |||
NasalCrom (cromolyn) |
- Citation: Kaur P, Chevalier R, Friesen C, Ryan J, Sherman A, Page S. Diagnostic role of fractional exhaled nitric oxide in pediatric eosinophilic esophagitis, relationship with gastric and duodenal eosinophils. World J Gastrointest Endosc 2023; 15(5): 407-419
- URL: https://www.wjgnet.com/1948-5190/full/v15/i5/407.htm
- DOI: https://dx.doi.org/10.4253/wjge.v15.i5.407